[1]张广平.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性[J].医学信息,2021,34(23):105-107.[doi:10.3969/j.issn.1006-1959.2021.23.030]
 ZHANG Guang-ping.Clinical Efficacy and Safety of Montelukast Sodium in the Treatment of Viral Asthma in Children[J].Medical Information,2021,34(23):105-107.[doi:10.3969/j.issn.1006-1959.2021.23.030]
点击复制

孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年23期
页码:
105-107
栏目:
论著
出版日期:
2021-12-01

文章信息/Info

Title:
Clinical Efficacy and Safety of Montelukast Sodium in the Treatment of Viral Asthma in Children
文章编号:
1006-1959(2021)23-0105-03
作者:
张广平
(青阳县人民医院儿科,安徽 青阳 242800)
Author(s):
ZHANG Guang-ping
(Department of Pediatrics,Qingyang County People’s Hospital,Qingyang 242800,Anhui,China)
关键词:
孟鲁司特钠异丙托溴铵病毒性小儿哮喘咳嗽
Keywords:
Montelukast sodiumIpratropium bromideViral asthma in childrenCough
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2021.23.030
文献标志码:
A
摘要:
目的 观察孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性。方法 选取2020年5月-2021年5月在我院诊治的84例病毒性小儿哮喘作为研究对象,采用随机数字表法分为对照组和观察组,各42例。对照组采用常规治疗,观察组在对照组基础上给予孟鲁司特钠治疗。比较两组治疗总有效率、症状消失时间、症状评分、不良反应发生情况、哮喘发作次数及复发率。结果 观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);观察组气喘、咳嗽消失时间短于对照组,差异有统计学意义(P<0.05);两组气喘、咳嗽、睡眠、运动后咳嗽或哮喘评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05);观察组平均哮喘发作次数、复发率均小于对照组,差异有统计学意义(P<0.05)。结论 孟鲁司特钠治疗病毒性小儿哮喘临床疗效确切,可缩短患儿症状消失时间,临床不良反应少,且减少哮喘发作次数,预防疾病复发。
Abstract:
Objective To observe the clinical efficacy and safety of montelukast sodium in the treatment of viral asthma in children.Methods A total of 84 children with viral asthma treated in our hospital from May 2020 to May 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, 42 cases in each group. The control group was treated with conventional therapy, and the observation group was treated with montelukast sodium on the basis of the control group ; the total effective rate, symptom disappearance time, symptom score, adverse reactions, asthma attack frequency and recurrence rate were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). The disappearance time of asthma and cough in the observation group was less than that in the control group, and the difference was statistically significant (P<0.05). The scores of asthma, cough, sleep, cough or asthma after exercise in the two groups were lower than those before treatment, and those in the observation group were lower than the control group, the differences were statistically significant (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). The average number of asthma attacks and recurrence rate in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.05).Conclusion Montelukast sodium is effective in the treatment of viral asthma in children, which can shorten the disappearance time of symptoms in children, reduce the number of asthma attacks, and prevent disease recurrence.

参考文献/References:

[1]管政.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性分析[J].吉林医学,2019,40(5):1015-1016.[2]于爽.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性评价[J].中国医药指南,2019,17(8):65.[3]石锦.孟鲁司特钠治疗小儿哮喘临床疗效及用药安全性分析[J].中国继续医学教育,2018,10(13):89-90.[4]杨洁,李静,周耀铃.孟鲁司特钠治疗小儿哮喘临床研究[J].实用药物与临床,2016,19(5):606-609.[5]卢志成,齐晓琳,谷蒙蒙,等.布地奈德、沙丁胺醇雾化吸入联合孟鲁司特钠治疗小儿哮喘的疗效观察[J].中国医院用药评价与分析,2018,18(10):54-56.[6]朱刚.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床效果及安全性评价[J].中国实用医药,2019,14(5):108-109.[7]谢蔓芳,胡玲,黎小年,等.孟鲁司特钠片联合沙美特罗替卡松粉吸入剂治疗学龄期细支气管哮喘儿童的临床研究[J].中国临床药理学杂志,2020,36(11):4.[8]杨丽炜,荣庆娜,冯兰英,等.孟鲁司特钠联合布地奈德吸入治疗小儿哮喘的效果及对气道功能、血清炎性因子的影响[J].临床误诊误治,2019,32(10):23-26.[9]柴斌英,万俊,包志丹,等.布地奈德雾化剂联合孟鲁司特钠治疗小儿哮喘患者的疗效及对血清炎性因子的影响[J].河北医药,2018,40(13):1969-1971,1975.[10]谢斌.孟鲁司特钠联合布地奈德气雾剂对小儿咳嗽变异性哮喘疗效及对血清炎症因子水平的影响[J].医学理论与实践,2017,30(13):1928-1929.[11]李华伟,寇会波,郭栓青.孟鲁司特钠治疗小儿哮喘临床效果、复发及不良反应研究[J].河北医药,2016,38(6):881-883.[12]万江,罗望梅,郑申健,等.布地奈德联合孟鲁司特钠治疗小儿咳嗽变异性哮喘的临床效果[J].中国医院用药评价与分析,2016,16(8):1057-1059.[13]黄莉,鲁利群,宁雪梅,等.布地奈德吸入联合孟鲁司特钠对小儿哮喘气道功能及血清炎症因子的影响[J].海南医学院学报,2018,24(1):64-66,70.[14]曾晓兵,杨丹,车敏.孟鲁司特钠治疗病毒性小儿哮喘的临床疗效及安全性分析[J].当代临床医刊,2020,4(23):20-22.[15]李云霞.孟鲁司特联合布地奈德治疗哮喘患儿的临床研究[J].药物评价研究,2016,39(4):656-659.[16]陈晓磊.孟鲁司特钠联合布地奈德治疗小儿哮喘急性发作疗效观察[J].中国药物评价,2017,34(1):44-45. [17]石锦.孟鲁司特钠治疗小儿哮喘临床疗效及用药安全性分析[J].中国继续医学教育,2018,10(13):101-102. [18]王莉萍.孟鲁司特钠治疗小儿哮喘的临床效果分析[J].河南医学研究,2018,27(11):97-98. [19]张艳红,张超.沙丁胺醇气雾剂联合孟鲁司特钠咀嚼片治疗小儿哮喘的临床疗效分析[J].临床医学研究与实践,2017,2(10):45-46. [20]吴凤霞.孟鲁司特钠治疗小儿咳嗽变异性哮喘的疗效分析[J].中国卫生标准管理,2016,7(19):84-85.

相似文献/References:

[1]李波.孟鲁司特钠联合酮替芬治疗小儿支气管炎的临床效果分析[J].医学信息,2018,31(02):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
 LI Bo.Clinical Analysis of Montelukast Sodium Combined With Ketotifen in the Treatment of Bronchitis in Children[J].Medical Information,2018,31(23):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
[2]尹静华.孟鲁司特钠治疗小儿哮喘的临床有效性分析[J].医学信息,2018,31(09):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
 YIN Jing-hua.Clinical Efficacy of Montelukast Sodium in Children with Asthma[J].Medical Information,2018,31(23):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
[3]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
 ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Medical Information,2018,31(23):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[4]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,32(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
 ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Medical Information,2019,32(23):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[5]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
 WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,32(23):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[6]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,32(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
 LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,32(23):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[7]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
 GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Medical Information,2019,32(23):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
[8]凌春艳.布地奈德气雾剂联合孟鲁司特钠治疗老年咳嗽变异性哮喘的疗效[J].医学信息,2020,33(07):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
 LING Chun-yan.Efficacy of Budesonide Aerosol Combined with Montelukast Sodium in the Treatment of Elderly Cough Variant Asthma[J].Medical Information,2020,33(23):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
[9]牛春生.孟鲁司特钠联合糠酸莫米松治疗过敏性鼻炎致轻中度腺样体肥大的效果[J].医学信息,2020,33(22):153.[doi:10.3969/j.issn.1006-1959.2020.22.044]
 NIU Chun-sheng.The Effect of Montelukast Sodium Combined with Mometasone Furoate in the Treatment of Mild to Moderate Adenoid Hypertrophy Caused by Allergic Rhinitis[J].Medical Information,2020,33(23):153.[doi:10.3969/j.issn.1006-1959.2020.22.044]
[10]金彩英.孟鲁司特钠治疗儿童呼吸道合胞病毒感染毛细支气管炎的效果及其对炎症因子的影响[J].医学信息,2022,35(01):162.[doi:10.3969/j.issn.1006-1959.2022.01.040]
 JIN Cai-ying.Effect of Montelukast Sodium on Bronchiolitis Caused by Respiratory Syncytial Virus Infection in Children and its Effect on Inflammatory Factors[J].Medical Information,2022,35(23):162.[doi:10.3969/j.issn.1006-1959.2022.01.040]

更新日期/Last Update: 1900-01-01